Cost-effectiveness simulation analysis of tenofovir disoproxil fumarate (tenofovir), lamivudine, adefovir dipivoxil (adefovir) and entecavir of HBeAg negative (-) patients with chronic hepatitis-B (CHB) in Spain

被引：2
|
作者：
Deniz, B. [1 ]
Buti, M. [2 ]
Brosa, M. [3 ]
Casado, M. A. [5 ]
Rueda, M. [4 ]
Everhard, F. [4 ]
Esteban, R.
机构：
[1] United BioSource Corp, Concord, MA USA
[2] Hosp Vall D Hebron, Dept Hepatol, Barcelona, Spain
[3] Oblikue Consulting, Barcelona, Spain
[4] Gilead Sci Inc, Foster City, CA USA
[5] Pharmacoecon & Outcomes Res, Madrid, Spain
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 48卷
关键词：
D O I：
10.1016/S0168-8278(08)60560-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
558
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS SIMULATION ANALYSIS OF TENOFOVIR DISOPROXIL FUMARATE (TDF), LAMIVUDINE (LAM), ADEFOVIR DIPIVOXIL (ADV) AND ENTECAVIR (ETV) IN HBEAG NEGATIVE (-) PATIENTS WITH CHRONIC HEPATITIS B (CHB) IN THE USA
    Deniz, H. B.
    Everhard, Francois
    [J]. HEPATOLOGY, 2008, 48 (04) : 744A - 744A
  • [2] Cost-effectiveness simulation analysis of tenofovir disoproxil fumarate (tenofovir) in HBeAg negative (-) patients with chronic hepatitis-B (CHB) in Italy and France
    Deniz, B.
    Everhard, F.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S210 - S210
  • [3] Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
    Marcellin, Patrick
    Heathcote, E. Jenny
    Buti, Maria
    Gane, Ed
    de Man, Robert A.
    Krastev, Zahary
    Germanidis, George
    Lee, Sam S.
    Flisiak, Robert
    Kaita, Kelly
    Manns, Michael
    Kotzev, Iskren
    Tchernev, Konstantin
    Buggisch, Peter
    Weilert, Frank
    Kurdas, Oya Ovung
    Shiffman, Mitchell L.
    Trinh, Huy
    Washington, Mary Kay
    Sorbel, Jeff
    Anderson, Jane
    Snow-Lampart, Andrea
    Mondou, Elsa
    Quinn, Joe
    Rousseau, Franck
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (23): : 2442 - 2455
  • [4] Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B
    Buti, M
    Casado, MA
    Calleja, JL
    Salmerón, J
    Aguilar, J
    Rueda, M
    Esteban, R
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (03) : 409 - 419
  • [5] Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
    Patterson, S. J.
    George, J.
    Strasser, S. I.
    Lee, A. U.
    Sievert, W.
    Nicoll, A. J.
    Desmond, P. V.
    Roberts, S. K.
    Locarnini, S.
    Bowden, S.
    Angus, P. W.
    [J]. GUT, 2011, 60 (02) : 247 - 254
  • [6] Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients
    Dan-Hong Yang
    Yuan-Jun Xie
    Nian-Feng Zhao
    Hong-Ying Pan
    Ming-Wei Li
    Hai-Jun Huang
    [J]. World Journal of Gastroenterology, 2015, (09) : 2746 - 2753
  • [7] Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients
    Yang, Dan-Hong
    Xie, Yuan-Jun
    Zhao, Nian-Feng
    Pan, Hong-Ying
    Li, Ming-Wei
    Huang, Hai-Jun
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (09) : 2746 - 2753
  • [8] Tenofovir disoproxil fumarate for patients with chronic hepatitis B who have previously failed lamivudine and adefovir
    Patterson, S. J.
    George, J.
    Strasser, S. I.
    Lee, A. U.
    Sievert, W.
    Nicoll, A. J.
    Desmonad, P. V.
    Roberts, S. K.
    Locarnini, S.
    Bowden, S.
    Angus, P. W.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A302 - A302
  • [9] Compare with safety and efficacy of entecavir and adefovir dipivoxil combination therapy and tenofovir disoproxil fumarate monotherapy for chronic hepatitis B patient with adefovir-resistant
    Lai, Ming-Chun
    Lian, Jiang-Shan
    Zhang, Wen-Jin
    Xu, Jun
    Zhou, Lin
    Zheng, Shu-Sen
    [J]. MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2020, 17 (01) : 627 - 635
  • [10] Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance
    Wang, Guiliang
    Liu, Yan
    Qiu, Ping
    Zhou, Shu-Feng
    Xu, Linfang
    Wen, Ping
    Wen, Jianbo
    Xiao, Xianzhong
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2839 - 2846
12345